Afrin Moisturizing Spray 0.05%, 15ml

Afrin Moisturizing Spray 0.05%, 15ml

• Symptomatic therapy of rhinitis (runny nose) of allergic and / or infectious-inflammatory etiology,

• sinusitis,

• eustachitis,

• hay fever.

Intranasal Shake the bottle vigorously before each use.

Before using the nasal spray for the first time, it must be 'calibrated' by pressing the spray head several times.

Adults and children over 6 years old - 2-3 injections into each nasal passage with an interval of 10-12 hours. In adults, the frequency of application can be increased up to 3 times / day in adults. It is not recommended to exceed the indicated dose.

1 ml of solution for intranasal administration contains oxymetazoline hydrochloride 0.5 mg

Excipients: microcrystalline cellulose and sodium carmellose (Avicel RC-591) - 30 mg, sodium hydrogen phosphate - 0.975 mg, sodium dihydrogen phosphate monohydrate - 5.525 mg, disodium edetate dihydrate - 0.3 mg, macrogol 1450 - 50 mg, povidone K29-32 - 30 mg, benzyl alcohol - 2.5 mg, chamomile flavor - 0.2 mg, benzalkonium chloride solution 17% - 1.471 mg, glycerol - 5 mg, purified water - qs up to 1 ml.

• Hypersensitivity to sympathomimetic drugs, to any component of the drug,

• atrophic rhinitis,

• the simultaneous use of inhibitors of manoamine oxidase (including a period of 14 days after their cancellation),

• children's age (up to 6 years).

Afrin moisturizing relieves congestion and helps to moisturize dry and irritated nasal mucosa:
Х Does not run out of the nose or down the throat
Х The effect occurs within 1 minute
Х Lasts up to 12 hours
Х Has a moisturizing effect

Composition:
1 ml solution for intranasal use contains oxymetazoline hydrochloride 0.5 mg.

Indications:
Symptomatic therapy of rhinitis (rhinitis) of allergic and / or infectious-inflammatory etiology, sinusitis, eustachitis, hay fever.

Contraindications:
Hypersensitivity to sympathomimetic drugs, to any component of the drug, atrophic rhinitis, the simultaneous use of inhibitors of manoamine oxidase (including a period of 14 days after their withdrawal), children (up to 6 years).

Method of administration and dosage:
Intranasal . Before each use, shake the bottle vigorously.

Before using the nasal spray for the first time, it must be 'calibrated' by pressing the spray head several times.

Adults and children over 6 years old - 2-3 injections into each nasal passage with an interval of 10-12 hours. In adults, the frequency of use can be increased up to 3 times / day in adults. It is not recommended to exceed the indicated dose.

Side effects:
In general, the drug is well tolerated and possible adverse reactions are usually mild and transient.

Transient dryness and burning of the nasal mucosa, dry mouth and throat, sneezing. With prolonged use - tachyphylaxis, reactive hyperemia and atrophy of the nasal mucosa. Benzalkonium chloride, which is part of the drug, can cause local skin reactions.